This live facilitated two-part course provides clinicians the knowledge and confidence to prescribe gender affirming hormone therapy (GAHT) based on the needs of their patient population utilising an informed consent model. Attendees will be supported to create a gender affirming practice and establish a business model for ongoing financial sustainability.
This course is for healthcare professionals practicing nationally. We are currently accepting registrations from across Australia.
CLICK HERE to access the course flyer.
Webinar details:
Platform: Online via Zoom
Dates:
- Part 1: Tuesday, 17 Nov 2026
- Part 2: Wednesday, 18 Nov 2026
Time:
- QLD: 6:30pm – 8:30pm (AEST)
- NSW / ACT / VIC / TAS: 7:30pm – 9:30pm (AEDT)
- SA: 7:00pm – 9:00pm (ACDT)
- NT: 6:00pm – 8:00pm (ACST)
- WA: 4:30pm – 6:30pm (AWST)
Speakers & Facilitators:
- Adjunct Prof Darren Russell (he/his) | Sexual Health Physician – Prism Health and Kardinia Health, Geelong
- Maggie Smith (she/they) | Nurse Practitioner – The Albion Centre
- Araz Ahmed (he/they) | Organisational Change Social Worker – Legal Aid, NSW
- Margot London (she/her) | Community Health Promotion Officer – Trans Health Equity, ACON
- Jane MacLeod (they/them) | General Practitioner QLD
Course Components:
1. Pre-requisite learning modules:
– Trans and Gender Diverse Sexual Health Care E-Learning
– Case Studies in Gender Affirming Hormone Therapy E-Learning.
2. Live online training: Attendance at two, two-hour live facilitated online training sessions
3. Post course assessment: An online competency assessment to be completed within one month of the facilitated training.
Learning Outcomes:
- Identify the diverse needs and experiences of trans and gender diverse people across different stages of life.
- Assess individual needs and develop gender-affirming care plans aligned with clients’ goals and desired outcomes.
- Assess and manage reproductive health, contraception and fertility considerations in gender-affirming care.
- Apply an informed consent model, including navigating consent, capacity and decision-making for young people.
- Implement practical strategies to deliver safe, affirming and evidence-based care in clinical practice.
Endorsement and CPD:
This is a CPD Accredited Activity for 2.5 Educational Activity and 2.0 Reviewing Performance hours under the RACGP CPD Program for the 2026-2028 triennium.
This course has been approved by ACRRM as an accredited activity. Allocated total 4.5PDP units for the 2026-2028 triennium.
Funding:
This course is supported by funding from the Australian Government Department of Health, Disability, and Ageing under the Quality Use of Diagnostics, Therapeutics and Pathology program.
Target Audience:
Clinicians currently or seeking to prescribe GAHT.
